SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001140361-19-002981
Filing Date
2019-02-13
Accepted
2019-02-13 11:23:03
Documents
1
Group Members
PHASE4 VENTURES III GENERAL PARTNER LTDPHASE4 VENTURES III GP LPPHASE4 VENTURES III LP

Document Format Files

Seq Description Document Type Size
1 SC 13G/A formsc13ga.htm SC 13G/A 154657
  Complete submission text file 0001140361-19-002981.txt   156293
Mailing Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-995-8200
OncoMed Pharmaceuticals Inc (Subject) CIK: 0001302573 (see all company filings)

IRS No.: 383572512 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87757 | Film No.: 19594277
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address GREEN PARK HOUSE 15 STRATTON STREET LONDON X0 W1J 8LQ
Business Address GREEN PARK HOUSE 15 STRATTON STREET LONDON X0 W1J 8LQ 44 0 20 3036 0050
Phase4 Partners Ltd (Filed by) CIK: 0001600023 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13G/A